This site is intended for UK healthcare professionals only

Diabetes Professional Care
15-16 November 2023, Olympia London

The UK's leading event for the entire team involved in the prevention, treatment and management of diabetes and its related conditions.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend Diabetes Professional Care

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website

DPC 2023

Subpage Hero



Navigating the GLP-1 challenges

15 Nov 2023
Clinical Theatre

Explore the evolving world of GLP-1 receptor agonists, their multifaceted benefits, and clinical considerations. Discover emerging GLP-1 and dual agonists and learn how they go beyond glycaemic control. Navigate the challenges of the national GLP-1 shortage while ensuring top-notch patient care. Join us for an insightful discussion on the future of diabetes management.

This educational session delves into the dynamic landscape of diabetes healthcare, focusing on GLP-1 receptor agonist therapies. It covers essential topics, including their mechanism, multifaceted benefits extending beyond glycaemic control, emerging GLP-1 and dual agonists, clinical considerations for prescribing, and strategies for navigating the national GLP-1 shortage while ensuring optimal patient care. Participants will gain a comprehensive understanding of these therapies and their role in shaping the future of diabetes management. Join us for an insightful discussion that equips you with the knowledge and tools to enhance patient outcomes in diabetes care.

Learning outcomes:

1. Understand the mechanism and clinical applications of GLP-1 receptor agonist therapies.
2. Evaluate the diverse benefits of GLP-1 receptor agonists beyond glycemic control, including cardiovascular advantages.
3. Identify emerging GLP-1 and dual agonists and their potential in diabetes management.
4. Examine key clinical considerations for prescribing GLP-1 receptor agonist therapies effectively.
5. Develop strategies to navigate and mitigate the impact of the national GLP-1 shortage on patient care.
6. Gain insights into the future of diabetes management, staying informed about evolving trends and challenges in healthcare.


Helen O'neil, Senior Medicines Optimisation Pharmacist – Tees Valley - NECS
Michael Skarlatos, Diabetes Specialist Dietitian & Education and Research Associate - Leicester Diabetes Centre